VIVUS, Inc. (NASDAQ:VVUS) – Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Stendra Gets FDA Go-Ahead For 15 Minutes Prior Use

Boston, MA 09/19/2014 (wallstreetpr) – Stendra, the erectile dysfunction drug developed collaboratively by VIVUS, Inc. (NASDAQ:VVUS) and Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) has been given the nod by the U.S. Food and Drug Administration to be used 15 minutes earlier. It is crucial to point out here that this drug was already approved by the FDA, […]

Endo International plc – Ordinary Shares (NASDAQ:ENDP) To Acquire Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) In $1.4 Billion

Boston, MA 09/18/2014 (wallstreetpr) – According to reports, Endo International plc – Ordinary Shares (NASDAQ:ENDP) has decided to make an unsolicited offer of $1.4 billion to acquire Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL). On the basis of the offer made by ENDP, each share of AUXL is valued at $28.10, which is fair enough in regard with […]